×

Remotely activated piezoelectric pump for delivery of biological agents to the intervertebral disc and spine

  • US 8,827,986 B2
  • Filed: 10/19/2009
  • Issued: 09/09/2014
  • Est. Priority Date: 10/19/2009
  • Status: Active Grant
First Claim
Patent Images

1. A method for osteogenetic treatment in a patient comprising:

  • surgically implanting a selectively controllable and inductively rechargeable spine pump with a wireless transceiver and with a fluid reservoir for holding an osteogenetic agent into a patient, the spine pump including a first accelerometer fixed thereto;

    fixing the spine pump to a selected vertebra of the patient, where the selected vertebra is to be fused to an adjacent vertebra;

    surgically implanting a spinal cage having a fluid distribution subsystem defined therein into a vertebra disc space between the selected vertebra and an adjacent vertebra, which is to be fused to the selected vertebra;

    fluidicly communicating the spine pump to the fluid distribution subsystem of the spinal cage;

    surgically implanting a fitting fixed to the adjacent vertebra;

    coupling a second accelerometer to the fitting fixed to the adjacent vertebra;

    electrically communicating the first and second accelerometers to the wireless transceiver in the spine pump;

    selectively dispensing selected amounts of osteogenetic agent from the fluid reservoir to the fluid distribution subsystem in the spinal cage over an extended time period of treatment during which the selected and adjacent vertebrae are fusing together, the amount of osteogenetic agent delivered to the fluid distribution subsystem in the spinal cage being alterable during the extended time period of treatment according to a set of received dosing instructions wirelessly transmitted to the receiver of the spine pump over a communications link exterior to the patient;

    calibrating the first and second accelerometers by means of the wireless transceiver when the patient and consequently the selected and adjacent vertebrae are stationary in space to remove the effect of gravity upon the calibration of the first and second accelerometers;

    monitoring the first and second accelerometers by means of the wireless transceiver while the patient is ambulatory;

    determining the vector difference in the outputs of the first and second accelerometers to assess the efficacy of osteogenetic treatment of the vertebra disc space between the selected and adjacent vertebrae; and

    selectively modifying amounts of the osteogenetic agent to be dispensed from the fluid reservoir to the fluid distribution subsystem in the spinal cage over an extended time period of treatment in response to the assessed efficacy of osteogenetic treatment of the vertebra disc space between the selected and adjacent vertebrae as determined by the vector difference in the outputs of the first and second accelerometers.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×